| The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. | |
| | |
MedLine Citation:
|
PMID: 3920775 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The response of components of the coagulation and fibrinolytic systems has been examined in patients undergoing minor and major elective surgery and receiving or not receiving subcutaneously administered prophylactic low molecular weight (LMW) heparin. Blood samples were withdrawn pre-operation (PO), post-anaesthesia (PA), during operation (DO) and 24 hours post-operation. Release of plasminogen activator occurred post anaesthesia at a time when factor VIII components were unchanged or decreased. Induction of anaesthesia decreased plasminogen (p less than 0.005) fibrinogen (p less than 0.02) ATIII (p less than 0.002) and fast a2-antiplasmin (p less than 0.005). During operation plasminogen activator release reached a peak in association with a moderate increase in factor VIII components. Heparin treatment produced a prolongation of APTT at DO (p less than 0.05) and at 24hr (p less than 0.002) stages, this prolongation being apparently unrelated to its concentration but did not prevent the rise of factor VIII components observed at 24 hr (p less than 0.02). Prekallikrein (p less than 0.05) and antithrombin III levels (p less than 0.05) were significantly higher whereas fast a2-antiplasmin (p less than 0.002) was significantly lower at 24 hours in patients undergoing major operation and treated with heparin. Protein C levels fell significantly at 24 hours in the untreated patient (p less than 0.014) and in the heparin treated group the fall was greater than the control group (p less than 0.007). At 24 hours other haemostatic and fibrinolytic components were unaffected by heparin treatment. |
| | |
Authors:
|
E Melissari; M F Scully; T Paes; V V Kakkar |
Related Documents
:
|
22608215 - New insights into therapy by mathematical analysis: recalcitrant granulated improved mo... 10958295 - Effort subclavian vein thrombosis: evolution of management. 11204585 - Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmo... 16331015 - Venous thromboembolic prophylaxis after elective total hip arthroplasty. 20493485 - A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide ... 19383585 - Postoperative pericardial effusion and posterior pericardiotomy, related or not? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Thrombosis research Volume: 37 ISSN: 0049-3848 ISO Abbreviation: Thromb. Res. Publication Date: 1985 Jan |
Date Detail:
|
Created Date: 1985-05-16 Completed Date: 1985-05-16 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0326377 Medline TA: Thromb Res Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 115-26 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Coagulation / drug effects* Factor VIII / analysis Fibrinogen / analysis Fibrinolysis / drug effects* Glycoproteins / analysis Heparin / pharmacology* Humans Middle Aged Molecular Weight Plasminogen / analysis Plasminogen Activators / analysis Protein C Surgical Procedures, Operative* |
| Chemical | |
Reg. No./Substance:
|
0/Glycoproteins; 0/Protein C; 9001-27-8/Factor VIII; 9001-32-5/Fibrinogen; 9001-91-6/Plasminogen; 9005-49-6/Heparin; EC 3.4.21.-/Plasminogen Activators |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neural tube defects caused by local anesthetics in early chick embryos.
Next Document: A new function for activated protein C: activated protein C prevents inhibition of plasminogen activ...